Ghrelin
Metabolic / GH AxisAlso known as: Growth Hormone Releasing Peptide, Lenomorelin, Hunger Hormone
Mechanism
The body's "hunger hormone" — a 28-amino acid peptide produced mainly in the stomach. It's the only known gut hormone that stimulates appetite. Ghrelin binds the same receptor (GHS-R1a) targeted by MK-677, GHRP-2, GHRP-6, and Hexarelin. It also stimulates growth hormone release, increases gastric motility, and drives reward-seeking behavior. Understanding ghrelin led to the development of the entire class of GH secretagogues.
Technical detail
28-amino acid peptide with a unique post-translational modification: octanoylation (C8 fatty acid) at Ser3 by GOAT enzyme (ghrelin O-acyltransferase). This acylation is essential for GHS-R1a binding and biological activity. Des-acyl ghrelin (non-octanoylated) is more abundant in circulation but signals through different, less characterized pathways. GHS-R1a (Growth Hormone Secretagogue Receptor 1a): Gq-coupled GPCR. Uniquely has ~50% constitutive activity (signals without ligand). Arcuate nucleus: ghrelin activates AgRP/NPY neurons (orexigenic) and inhibits POMC neurons (anorexigenic). Pituitary: direct GH release via GHS-R1a on somatotrophs. Hippocampus: promotes neurogenesis and memory consolidation. VTA/NAc: enhances dopaminergic reward signaling. Gastric: promotes motility via vagal afferents. Discovered by Kojima et al. (1999) Nature. Ghrelin levels peak before meals, drop after eating. Inverse agonists (PF-5190457) in Phase 1 for alcohol use disorder.
Effects
## Ghrelin — System-by-System Effects ### Appetite/Metabolic System (Primary) - **Hunger hormone**: Ghrelin is the only known orexigenic (appetite-stimulating) hormone. Produced primarily by gastric fundus cells (X/A-like cells), ghrelin levels rise before meals and fall after eating. It is the physiological hunger signal. [Tier 1 — well-established endocrinology] - **Hypothalamic signaling**: Ghrelin crosses the blood-brain barrier and activates NPY/AgRP neurons in the arcuate nucleus of the hypothalamus, stimulating appetite and food-seeking behavior. [Tier 1] - **Meal initiation**: Peak ghrelin levels correspond to habitual meal times, suggesting ghrelin mediates learned meal patterns, not just caloric need. This is why hunger comes at "meal times" even when not calorically depleted. [Tier 1] - **Post-meal suppression**: Ghrelin is suppressed by food intake, especially protein and carbohydrates. Fat is a weaker ghrelin suppressor, which partly explains why high-fat meals are less satiating calorie-for-calorie. [Tier 1] - **Hedonic eating**: Ghrelin enhances the reward value of food through mesolimbic dopamine pathways. It makes food taste better and increases motivation to eat. [Tier 1] ### Growth Hormone System - **GH secretagogue**: Ghrelin is the endogenous ligand for the GH secretagogue receptor (GHSR1a). It stimulates pulsatile GH release from the anterior pituitary. [Tier 1] - **GH amplitude**: Ghrelin increases the amplitude (but not frequency) of GH pulses. This is distinct from GHRH, which increases both. [Tier 1] - **IGF-1 downstream**: GH stimulated by ghrelin increases hepatic IGF-1 production. The ghrelin → GH → IGF-1 axis is a key anabolic pathway. [Tier 1] ### Gastrointestinal System - **Gastric motility**: Ghrelin stimulates gastric motility and emptying (prokinetic). Used experimentally for gastroparesis. [Tier 2] - **Migrating motor complex**: Ghrelin helps initiate the migrating motor complex (MMC), the "housekeeper wave" that cleans the GI tract between meals. This is why intermittent fasting and meal spacing support GI health. [Tier 1] ### Cardiovascular System - **Vasodilation**: Ghrelin has vasodilatory effects, reducing blood pressure. [Tier 2] - **Cardioprotection**: Some evidence for cardioprotective effects during ischemia. [Tier 2] ### Neurological/Psychological System - **Mood regulation**: Ghrelin has anxiolytic and antidepressant effects in animal models. The "hangry" phenomenon may relate to ghrelin's interaction with stress systems. [Tier 2] - **Memory and learning**: GHSR1a is expressed in hippocampus. Ghrelin enhances memory consolidation, particularly for food-related memories (evolutionary advantage). [Tier 2] - **Stress response**: Ghrelin rises during psychological stress and may serve as a stress coping signal. Stress eating may be partially ghrelin-mediated. [Tier 2] ### Body Composition - **Adiposity regulation**: Chronically elevated ghrelin promotes fat storage, while chronically suppressed ghrelin (as after bariatric surgery) contributes to sustained weight loss. [Tier 1] - **Muscle preservation**: Ghrelin's GH-stimulating effects support lean mass. Ghrelin agonists are being developed for cachexia and sarcopenia. [Tier 2]
Practitioner Guide
## Ghrelin — Practitioner Guide ### Clinical Profile Ghrelin is a 28-amino acid peptide with a unique octanoyl modification (acylation) required for GHSR1a binding. It is the body's primary hunger signal and a potent GH secretagogue. Understanding ghrelin biology is critical for weight management, GH optimization, and GI health. ### Optimizing Endogenous Ghrelin Signaling (The Key Clinical Application) Rather than administering exogenous ghrelin (which is not practical for most applications), understanding ghrelin allows practitioners to optimize patients' endogenous signaling through diet, timing, and lifestyle. #### For Weight Loss Patients (Taming Ghrelin) - **Protein-first meals**: Protein is the most potent ghrelin suppressor. Starting meals with protein (20-30g) creates a stronger and more sustained ghrelin suppression than carbs or fat alone. [Tier 1] - **Meal regularity**: Ghrelin entrains to habitual meal times. Consistent meal timing reduces "unexpected" hunger surges. Patients who eat at random times have more chaotic ghrelin patterns. [Tier 2] - **Sleep optimization**: Sleep deprivation (even one night) increases ghrelin and decreases leptin, creating a hormonal setup for overeating. This is one of the strongest lifestyle interventions for appetite control. [Tier 1 — Spiegel et al., 2004] - **Post-bariatric surgery**: Gastric sleeve removes the gastric fundus (primary ghrelin source), dramatically reducing ghrelin levels. This is a major mechanism of sustained weight loss after sleeve gastrectomy — hunger simply disappears. Bypass has similar but less dramatic ghrelin effects. [Tier 1] - **GLP-1 agonist context**: Semaglutide and tirzepatide reduce appetite through GLP-1/GIP pathways but also modulate ghrelin indirectly. Understanding both systems helps explain the dramatic efficacy of these drugs. - **Fiber and volume**: High-volume, fiber-rich foods promote gastric distension, which suppresses ghrelin through vagal afferents. This is why salad before a meal reduces total intake. #### For Underweight/Cachexia Patients (Boosting Ghrelin) - **Ghrelin agonists**: Anamorelin (approved in Japan for cancer cachexia) is a ghrelin receptor agonist that stimulates appetite and lean mass. [Tier 1 for anamorelin] - **MK-677 (Ibutamoren)**: Non-peptide GHSR1a agonist. Potently raises ghrelin-pathway signaling, GH, and appetite. Widely used in the peptide community for GH elevation. [Tier 2] - **Growth hormone secretagogue peptides**: GHRP-2, GHRP-6, hexarelin, and ipamorelin are synthetic GH secretagogues that work through or alongside ghrelin pathways. GHRP-6 is closest to ghrelin in its appetite-stimulating effects. [Tier 2] #### For GI Health (Leveraging Ghrelin Biology) - **Meal spacing for MMC**: The migrating motor complex requires ~90-120 minutes of fasting to activate. Ghrelin helps initiate this. Constant snacking prevents MMC activation, contributing to SIBO and GI motility issues. [Tier 1 for MMC physiology] - **Intermittent fasting benefits**: Part of the GI benefit of intermittent fasting is enhanced MMC activation and ghrelin rhythm normalization. [Tier 2] - **Gastroparesis**: Ghrelin agonists (relamorelin) have been studied for diabetic gastroparesis with promising results. [Tier 2] ### Practical Takeaways for Patient Counseling 1. "Hunger is a hormone, not a moral failing" — normalizes ghrelin biology for patients struggling with appetite 2. "Eat protein first at every meal" — most actionable ghrelin-management strategy 3. "Consistent meal times train your hunger hormone" — reduces chaotic hunger 4. "Sleep is an appetite control tool" — motivation for sleep hygiene 5. "Meal spacing lets your gut clean itself" — reduces snacking, supports GI health 6. "Post-surgery hunger reduction is real and biological" — for bariatric patients ### Exogenous Ghrelin Use - Not practical for routine clinical use (requires IV/SC infusion, very short half-life, ~10 minutes) - Research tool for studying appetite physiology - Ghrelin agonists (anamorelin, MK-677) are used clinically instead - GHRP-6 has the most ghrelin-like appetite stimulation among GH secretagogue peptides
Research Summary
## Ghrelin — Research Summary ### Tier 1 (Strong Clinical Evidence) - **Discovery and physiology**: Kojima et al. (1999) identified ghrelin. Subsequent research has thoroughly characterized its role in appetite, GH secretion, and metabolism. - **Hunger regulation**: Extensive human studies confirming preprandial rise, postprandial suppression, and meal entrainment. - **Sleep and appetite**: Spiegel et al. (2004) and subsequent studies demonstrate sleep deprivation increases ghrelin and appetite. Well-replicated. - **Bariatric surgery**: Dramatic ghrelin reduction after gastric sleeve is well-documented and contributes to surgical efficacy. Multiple large studies. - **Protein satiety**: Protein's superior ghrelin suppression is demonstrated in multiple controlled feeding studies. - **Anamorelin**: Approved in Japan for cancer cachexia. Phase 3 (ROMANA trials) showed improved appetite, lean mass, and body weight in NSCLC cachexia patients. ### Tier 2 (Moderate Evidence) - **Gastroparesis**: Relamorelin (ghrelin agonist) showed improved gastric emptying in Phase 2 trials for diabetic gastroparesis. - **Stress and ghrelin**: Animal and human studies linking psychological stress to ghrelin elevation and stress eating. - **Mood effects**: Preclinical data on ghrelin's anxiolytic and antidepressant properties. Human data is limited. - **MK-677**: Extensive human data showing GH and IGF-1 elevation, appetite increase, and sleep improvement. Not FDA-approved but widely studied. ### Tier 3 (Emerging) - **Ghrelin in aging**: Ghrelin resistance (analogous to insulin and leptin resistance) may develop with aging. This is an emerging concept. - **Personalized nutrition**: Using ghrelin response patterns to individualize meal timing and composition. ### Key Research Gaps - Ghrelin resistance as a concept needs more validation - Long-term ghrelin agonist safety in non-cachexia populations - Optimal strategies for ghrelin management in GLP-1 agonist era